R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism

Journal of Dermatological Science

Volumn 13, Issue 2, 1996, Pages 134-139

  Matsunaga, Jun ^a   Dakeishi, Miwako ^a   Shimizu, Hiroshi ^b   Tomita, Yasushi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Albinism; Ethnology; Mutation; Tyrosinase

Indexed keywords

DNA; MONOPHENOL MONOOXYGENASE;

ALBINISM; ARTICLE; ENZYME ACTIVITY; ETHNOLOGY; GENE SEQUENCE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; JAPAN; MUTATION; PRIORITY JOURNAL;

ALBINISM, OCULOCUTANEOUS; ALLELES; AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; EXONS; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; JAPAN; MALE; MONOPHENOL MONOOXYGENASE; POINT MUTATION;

EID: 0030297582     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(96)00519-1     Document Type: Article

References (13)

1. [1] Oetting WS, King RA. Molecular basis of oculocutaneous albinism. J Invest Dermatol 103: 131S-136S, 1994.
2. [2] Tomita Y, Takeda A, Okinaga S, Tagami H, Shibahara S. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem Biophys Res Commun 164: 990-996, 1989.
3. [3] Takeda A, Tomita Y, Matsunaga J, Tagami H, Shibahara S. Molecular basis of tyrosinase-negative oculocutaneous albinism. J Biol Chem 265: 17792-17797, 1990.
4. [4] Shimizu H, Niizeki H, Suzumori K, Aozaki R, Kawaguchi R, Hikiji K, Nishikawa T. Prenatal diagnosis of oculocutaneous albinism by analysis of the fetal tyrosinase gene. J Invest Dermatol 103: 104-106, 1994.
5. [5] Okayama H, Curiel DT, Blantly ML, Hohnes MD, Crystal RG. Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med 114: 105-113, 1989.
6. [6] Matsunaga J, Tomita Y, Tagami H. Detection of point mutations in human tyrosinase gene by improved allele-specific amplification. Exp Dermatol 4: 377-381, 1995.
7. [7] Tohda H, Oikawa A, Katsuki T, Hinuma Y, Seiji M. A convenient method of establishing permanent lines of xeroderma pigmentosum cells. Cancer Res 38: 253-256, 1978.
8. [8] Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491, 1988.
9. [9] Giebel LB, Strunk KM, Spritz RA. Organization and nucleotide sequence of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics 9: 435-445, 1991.
10. [10] Tripathi RK, Bundey S, Musarella MA, Droetto S, Strunk KM, Holmes SA, Spritz RA. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA). Am J Hum Genet 53: 1173-1179, 1993.
11. [11] Gershoni-Baruch R, Rosenmann A, Droetto S, Holmes S, Tripathi RK, Spritz RA. Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel. Am J Hum Genet 54: 586-594, 1994.
12. [12] Park KC, Lee YS, Kim KH. Molecular analysis of oculocutaneous albinism in Koreans. J Invest Dermatol 104: 626, 1995.
13. [13] Shimizu H, Ishiko A, Kikuchi A, Akiyama M, Suzumori K, Nishikawa T. Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism by electron microscopic DOPA reaction test of fetal skin. Prenat Diagn 14: 443-450, 1994.